UniProt ID | PPHLN_HUMAN | |
---|---|---|
UniProt AC | Q8NEY8 | |
Protein Name | Periphilin-1 {ECO:0000303|PubMed:12853457} | |
Gene Name | PPHLN1 {ECO:0000312|HGNC:HGNC:19369} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 458 | |
Subcellular Localization | Nucleus . Cytoplasm . Chromosome . In undifferentiated keratinocytes expressed in speckle-type nuclear granules and at the nuclear membrane, but in the differentiated keratinocytes colocalized with periplakin at the cell periphery and at cell-cell ju | |
Protein Description | Component of the HUSH complex, a multiprotein complex that mediates epigenetic repression. The HUSH complex is recruited to genomic loci rich in H3K9me3 and is probably required to maintain transcriptional silencing by promoting recruitment of SETDB1, a histone methyltransferase that mediates further deposition of H3K9me3. In the HUSH complex, contributes to the maintenance of the complex at chromatin. [PubMed: 26022416 Acts as a transcriptional corepressor and regulates the cell cycle, probably via the HUSH complex] | |
Protein Sequence | MWSEGRYEYERIPRERAPPRSHPSDGYNRLVNIVPKKPPLLDRPGEGSYNRYYSHVDYRDYDEGRSFSHDRRSGPPHRGDESGYRWTRDDHSASRQPEYRDMRDGFRRKSFYSSHYARERSPYKRDNTFFRESPVGRKDSPHSRSGSSVSSRSYSPERSKSYSFHQSQHRKSVRPGASYKRQNEGNPERDKERPVQSLKTSRDTSPSSGSAVSSSKVLDKPSRLTEKELAEAASKWAAEKLEKSDESNLPEISEYEAGSTAPLFTDQPEEPESNTTHGIELFEDSQLTTRSKAIASKTKEIEQVYRQDCETFGMVVKMLIEKDPSLEKSIQFALRQNLHEIESAGQTWQQVPPVRNTEMDHDGTPENEGEETAQSAPQPPQAPQPLQPRKKRVRRTTQLRRTTGAPDITWGMLKKTTQEAERILLRTQTPFTPENLFLAMLSVVHCNSRKDVKPENKQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MWSEGRYEYE -----CCCCCCCCCC | 28.95 | 29083192 | |
3 (in isoform 7) | Phosphorylation | - | 28.95 | 25072903 | |
4 (in isoform 7) | Phosphorylation | - | 31.98 | 25072903 | |
7 | Phosphorylation | -MWSEGRYEYERIPR -CCCCCCCCCCCCCH | 33.45 | 26714015 | |
9 | Phosphorylation | WSEGRYEYERIPRER CCCCCCCCCCCCHHH | 11.11 | 29083192 | |
13 (in isoform 7) | Phosphorylation | - | 38.00 | 25072903 | |
21 | Phosphorylation | RERAPPRSHPSDGYN HHHCCCCCCCCCCCH | 45.59 | 30576142 | |
21 (in isoform 3) | Phosphorylation | - | 45.59 | - | |
24 | Phosphorylation | APPRSHPSDGYNRLV CCCCCCCCCCCHHHE | 37.94 | 30576142 | |
24 (in isoform 3) | Phosphorylation | - | 37.94 | - | |
27 | Phosphorylation | RSHPSDGYNRLVNIV CCCCCCCCHHHEEEC | 11.33 | - | |
28 (in isoform 5) | Phosphorylation | - | 36.02 | - | |
28 (in isoform 6) | Phosphorylation | - | 36.02 | - | |
31 (in isoform 5) | Phosphorylation | - | 4.08 | - | |
31 (in isoform 6) | Phosphorylation | - | 4.08 | - | |
32 | Phosphorylation | DGYNRLVNIVPKKPP CCCHHHEEECCCCCC | 33.85 | 32142685 | |
37 | Ubiquitination | LVNIVPKKPPLLDRP HEEECCCCCCCCCCC | 45.88 | - | |
37 | Sumoylation | LVNIVPKKPPLLDRP HEEECCCCCCCCCCC | 45.88 | - | |
37 | Acetylation | LVNIVPKKPPLLDRP HEEECCCCCCCCCCC | 45.88 | 26051181 | |
37 | Sumoylation | LVNIVPKKPPLLDRP HEEECCCCCCCCCCC | 45.88 | - | |
37 | Ubiquitination | LVNIVPKKPPLLDRP HEEECCCCCCCCCCC | 45.88 | - | |
37 (in isoform 3) | Phosphorylation | - | 45.88 | 25849741 | |
39 (in isoform 3) | Phosphorylation | - | 55.20 | 29116813 | |
43 | Methylation | KKPPLLDRPGEGSYN CCCCCCCCCCCCCCC | 40.88 | 115488277 | |
44 (in isoform 5) | Phosphorylation | - | 44.87 | 25849741 | |
44 (in isoform 6) | Phosphorylation | - | 44.87 | 25849741 | |
46 (in isoform 5) | Phosphorylation | - | 47.88 | 29116813 | |
46 (in isoform 6) | Phosphorylation | - | 47.88 | 29116813 | |
48 | Phosphorylation | LDRPGEGSYNRYYSH CCCCCCCCCCCCCCC | 18.22 | 25159151 | |
49 | Phosphorylation | DRPGEGSYNRYYSHV CCCCCCCCCCCCCCC | 17.95 | - | |
52 | Phosphorylation | GEGSYNRYYSHVDYR CCCCCCCCCCCCCCC | 12.99 | 28796482 | |
53 | Phosphorylation | EGSYNRYYSHVDYRD CCCCCCCCCCCCCCC | 6.78 | 28796482 | |
54 | Phosphorylation | GSYNRYYSHVDYRDY CCCCCCCCCCCCCCC | 14.22 | 28796482 | |
55 | Phosphorylation | SYNRYYSHVDYRDYD CCCCCCCCCCCCCCC | 10.59 | 32142685 | |
58 | Phosphorylation | RYYSHVDYRDYDEGR CCCCCCCCCCCCCCC | 12.33 | 28796482 | |
61 | Phosphorylation | SHVDYRDYDEGRSFS CCCCCCCCCCCCCCC | 13.59 | 28796482 | |
62 | Phosphorylation | HVDYRDYDEGRSFSH CCCCCCCCCCCCCCC | 57.05 | 32142685 | |
66 | Phosphorylation | RDYDEGRSFSHDRRS CCCCCCCCCCCCCCC | 41.79 | 24719451 | |
68 | Phosphorylation | YDEGRSFSHDRRSGP CCCCCCCCCCCCCCC | 26.23 | 23312004 | |
73 | Phosphorylation | SFSHDRRSGPPHRGD CCCCCCCCCCCCCCC | 57.45 | 29496963 | |
78 | Methylation | RRSGPPHRGDESGYR CCCCCCCCCCCCCCC | 61.09 | 81026725 | |
78 | Phosphorylation | RRSGPPHRGDESGYR CCCCCCCCCCCCCCC | 61.09 | 32142685 | |
82 | Phosphorylation | PPHRGDESGYRWTRD CCCCCCCCCCCCCCC | 45.95 | 28555341 | |
85 | Phosphorylation | RGDESGYRWTRDDHS CCCCCCCCCCCCCCC | 31.64 | 32645325 | |
92 | Phosphorylation | RWTRDDHSASRQPEY CCCCCCCCCCCCCCH | 34.63 | 23401153 | |
94 | Phosphorylation | TRDDHSASRQPEYRD CCCCCCCCCCCCHHH | 34.17 | 30183078 | |
99 | Phosphorylation | SASRQPEYRDMRDGF CCCCCCCHHHHHHHH | 20.70 | 23403867 | |
100 | Phosphorylation | ASRQPEYRDMRDGFR CCCCCCHHHHHHHHH | 29.59 | 33259812 | |
105 | Ubiquitination | EYRDMRDGFRRKSFY CHHHHHHHHHHHHHH | 13.95 | 29967540 | |
107 | Phosphorylation | RDMRDGFRRKSFYSS HHHHHHHHHHHHHHH | 51.12 | 33259812 | |
107 | Ubiquitination | RDMRDGFRRKSFYSS HHHHHHHHHHHHHHH | 51.12 | 33845483 | |
109 | Sumoylation | MRDGFRRKSFYSSHY HHHHHHHHHHHHHHC | 40.43 | - | |
109 | Sumoylation | MRDGFRRKSFYSSHY HHHHHHHHHHHHHHC | 40.43 | 28112733 | |
110 | Phosphorylation | RDGFRRKSFYSSHYA HHHHHHHHHHHHHCH | 27.83 | 25159151 | |
112 | Phosphorylation | GFRRKSFYSSHYARE HHHHHHHHHHHCHHH | 19.16 | 21945579 | |
112 | Ubiquitination | GFRRKSFYSSHYARE HHHHHHHHHHHCHHH | 19.16 | 29967540 | |
113 | Phosphorylation | FRRKSFYSSHYARER HHHHHHHHHHCHHHC | 14.50 | 21945579 | |
114 | Phosphorylation | RRKSFYSSHYARERS HHHHHHHHHCHHHCC | 14.78 | 21945579 | |
115 | Ubiquitination | RKSFYSSHYARERSP HHHHHHHHCHHHCCC | 17.84 | 32015554 | |
116 | Phosphorylation | KSFYSSHYARERSPY HHHHHHHCHHHCCCC | 14.86 | 21945579 | |
117 | Phosphorylation | SFYSSHYARERSPYK HHHHHHCHHHCCCCC | 11.05 | 32142685 | |
121 | Phosphorylation | SHYARERSPYKRDNT HHCHHHCCCCCCCCC | 28.03 | 30266825 | |
123 | Phosphorylation | YARERSPYKRDNTFF CHHHCCCCCCCCCCC | 21.65 | 30266825 | |
128 | Phosphorylation | SPYKRDNTFFRESPV CCCCCCCCCCCCCCC | 28.56 | 29255136 | |
131 | Phosphorylation | KRDNTFFRESPVGRK CCCCCCCCCCCCCCC | 39.01 | 32645325 | |
133 | Phosphorylation | DNTFFRESPVGRKDS CCCCCCCCCCCCCCC | 22.19 | 29255136 | |
138 | Phosphorylation | RESPVGRKDSPHSRS CCCCCCCCCCCCCCC | 57.54 | 32645325 | |
140 | Phosphorylation | SPVGRKDSPHSRSGS CCCCCCCCCCCCCCC | 27.78 | 30278072 | |
143 | Phosphorylation | GRKDSPHSRSGSSVS CCCCCCCCCCCCCCC | 31.37 | 29743597 | |
144 | Ubiquitination | RKDSPHSRSGSSVSS CCCCCCCCCCCCCCC | 41.84 | 24816145 | |
145 | Phosphorylation | KDSPHSRSGSSVSSR CCCCCCCCCCCCCCC | 46.14 | 28450419 | |
146 | Ubiquitination | DSPHSRSGSSVSSRS CCCCCCCCCCCCCCC | 23.88 | 29967540 | |
147 | Phosphorylation | SPHSRSGSSVSSRSY CCCCCCCCCCCCCCC | 28.90 | 28450419 | |
148 | Phosphorylation | PHSRSGSSVSSRSYS CCCCCCCCCCCCCCC | 29.55 | 28450419 | |
150 | Phosphorylation | SRSGSSVSSRSYSPE CCCCCCCCCCCCCCC | 23.21 | 25159151 | |
151 | Phosphorylation | RSGSSVSSRSYSPER CCCCCCCCCCCCCCC | 24.08 | 30576142 | |
151 | Ubiquitination | RSGSSVSSRSYSPER CCCCCCCCCCCCCCC | 24.08 | 24816145 | |
153 | Phosphorylation | GSSVSSRSYSPERSK CCCCCCCCCCCCCCC | 31.73 | 23927012 | |
153 | Ubiquitination | GSSVSSRSYSPERSK CCCCCCCCCCCCCCC | 31.73 | 32015554 | |
154 | Phosphorylation | SSVSSRSYSPERSKS CCCCCCCCCCCCCCC | 27.43 | 30576142 | |
155 | Phosphorylation | SVSSRSYSPERSKSY CCCCCCCCCCCCCCC | 22.87 | 28355574 | |
157 | Phosphorylation | SSRSYSPERSKSYSF CCCCCCCCCCCCCCC | 64.74 | 32645325 | |
159 | Phosphorylation | RSYSPERSKSYSFHQ CCCCCCCCCCCCCCH | 25.04 | 17287340 | |
160 | Sumoylation | SYSPERSKSYSFHQS CCCCCCCCCCCCCHH | 60.68 | 28112733 | |
160 | Ubiquitination | SYSPERSKSYSFHQS CCCCCCCCCCCCCHH | 60.68 | 32015554 | |
161 | Phosphorylation | YSPERSKSYSFHQSQ CCCCCCCCCCCCHHH | 27.53 | 23401153 | |
161 | Ubiquitination | YSPERSKSYSFHQSQ CCCCCCCCCCCCHHH | 27.53 | 32015554 | |
162 | Phosphorylation | SPERSKSYSFHQSQH CCCCCCCCCCCHHHH | 21.06 | 27794612 | |
163 | Phosphorylation | PERSKSYSFHQSQHR CCCCCCCCCCHHHHH | 24.28 | 23401153 | |
165 | Ubiquitination | RSKSYSFHQSQHRKS CCCCCCCCHHHHHCC | 22.05 | 29967540 | |
166 | Ubiquitination | SKSYSFHQSQHRKSV CCCCCCCHHHHHCCC | 42.66 | 27667366 | |
167 | Phosphorylation | KSYSFHQSQHRKSVR CCCCCCHHHHHCCCC | 21.27 | 23401153 | |
167 | Ubiquitination | KSYSFHQSQHRKSVR CCCCCCHHHHHCCCC | 21.27 | 29967540 | |
168 | Ubiquitination | SYSFHQSQHRKSVRP CCCCCHHHHHCCCCC | 33.56 | 32015554 | |
171 | Sumoylation | FHQSQHRKSVRPGAS CCHHHHHCCCCCCHH | 51.70 | - | |
171 | Sumoylation | FHQSQHRKSVRPGAS CCHHHHHCCCCCCHH | 51.70 | - | |
172 | Phosphorylation | HQSQHRKSVRPGASY CHHHHHCCCCCCHHH | 24.26 | 23401153 | |
172 | Ubiquitination | HQSQHRKSVRPGASY CHHHHHCCCCCCHHH | 24.26 | 32015554 | |
173 | Ubiquitination | QSQHRKSVRPGASYK HHHHHCCCCCCHHHC | 10.84 | 27667366 | |
178 | Phosphorylation | KSVRPGASYKRQNEG CCCCCCHHHCCCCCC | 36.78 | 23401153 | |
178 (in isoform 9) | Phosphorylation | - | 36.78 | 24719451 | |
179 | Phosphorylation | SVRPGASYKRQNEGN CCCCCHHHCCCCCCC | 15.06 | 26074081 | |
179 | Ubiquitination | SVRPGASYKRQNEGN CCCCCHHHCCCCCCC | 15.06 | 32015554 | |
180 | Acetylation | VRPGASYKRQNEGNP CCCCHHHCCCCCCCC | 45.04 | 25953088 | |
180 | Sumoylation | VRPGASYKRQNEGNP CCCCHHHCCCCCCCC | 45.04 | 28112733 | |
180 | Ubiquitination | VRPGASYKRQNEGNP CCCCHHHCCCCCCCC | 45.04 | 32015554 | |
185 | Acetylation | SYKRQNEGNPERDKE HHCCCCCCCCCCCCC | 63.64 | 19608861 | |
185 | Ubiquitination | SYKRQNEGNPERDKE HHCCCCCCCCCCCCC | 63.64 | 27667366 | |
186 | Phosphorylation | YKRQNEGNPERDKER HCCCCCCCCCCCCCC | 29.13 | 32645325 | |
186 (in isoform 9) | Phosphorylation | - | 29.13 | 29666759 | |
187 | Acetylation | KRQNEGNPERDKERP CCCCCCCCCCCCCCC | 49.18 | 19608861 | |
187 | Ubiquitination | KRQNEGNPERDKERP CCCCCCCCCCCCCCC | 49.18 | 32015554 | |
188 (in isoform 9) | Phosphorylation | - | 76.99 | 24719451 | |
191 | 2-Hydroxyisobutyrylation | EGNPERDKERPVQSL CCCCCCCCCCCCCCC | 62.94 | - | |
192 | Acetylation | GNPERDKERPVQSLK CCCCCCCCCCCCCCC | 67.51 | 19608861 | |
192 | Ubiquitination | GNPERDKERPVQSLK CCCCCCCCCCCCCCC | 67.51 | 27667366 | |
193 | Phosphorylation | NPERDKERPVQSLKT CCCCCCCCCCCCCCC | 42.29 | 32645325 | |
197 | Phosphorylation | DKERPVQSLKTSRDT CCCCCCCCCCCCCCC | 31.87 | 30266825 | |
199 | Sumoylation | ERPVQSLKTSRDTSP CCCCCCCCCCCCCCC | 50.10 | 28112733 | |
199 | Ubiquitination | ERPVQSLKTSRDTSP CCCCCCCCCCCCCCC | 50.10 | 24816145 | |
200 | Phosphorylation | RPVQSLKTSRDTSPS CCCCCCCCCCCCCCC | 34.00 | 23927012 | |
201 | Phosphorylation | PVQSLKTSRDTSPSS CCCCCCCCCCCCCCC | 26.94 | 23927012 | |
201 | Ubiquitination | PVQSLKTSRDTSPSS CCCCCCCCCCCCCCC | 26.94 | 29967540 | |
204 | Phosphorylation | SLKTSRDTSPSSGSA CCCCCCCCCCCCCCC | 41.23 | 22167270 | |
205 | Phosphorylation | LKTSRDTSPSSGSAV CCCCCCCCCCCCCCC | 27.37 | 29255136 | |
206 | Ubiquitination | KTSRDTSPSSGSAVS CCCCCCCCCCCCCCC | 34.31 | 24816145 | |
207 | Phosphorylation | TSRDTSPSSGSAVSS CCCCCCCCCCCCCCC | 47.28 | 22167270 | |
208 | Phosphorylation | SRDTSPSSGSAVSSS CCCCCCCCCCCCCCH | 39.90 | 23401153 | |
208 | Ubiquitination | SRDTSPSSGSAVSSS CCCCCCCCCCCCCCH | 39.90 | 32015554 | |
210 | Phosphorylation | DTSPSSGSAVSSSKV CCCCCCCCCCCCHHC | 27.69 | 23401153 | |
212 | Phosphorylation | SPSSGSAVSSSKVLD CCCCCCCCCCHHCCC | 6.46 | 32645325 | |
213 | Phosphorylation | PSSGSAVSSSKVLDK CCCCCCCCCHHCCCC | 28.72 | 23401153 | |
214 | Phosphorylation | SSGSAVSSSKVLDKP CCCCCCCCHHCCCCC | 27.81 | 23401153 | |
215 | Phosphorylation | SGSAVSSSKVLDKPS CCCCCCCHHCCCCCC | 21.19 | 23927012 | |
215 | Ubiquitination | SGSAVSSSKVLDKPS CCCCCCCHHCCCCCC | 21.19 | 33845483 | |
216 | Acetylation | GSAVSSSKVLDKPSR CCCCCCHHCCCCCCC | 49.08 | 25953088 | |
216 | Ubiquitination | GSAVSSSKVLDKPSR CCCCCCHHCCCCCCC | 49.08 | 32015554 | |
220 | Acetylation | SSSKVLDKPSRLTEK CCHHCCCCCCCCCHH | 40.51 | 25953088 | |
220 | Ubiquitination | SSSKVLDKPSRLTEK CCHHCCCCCCCCCHH | 40.51 | 29967540 | |
221 | Acetylation | SSKVLDKPSRLTEKE CHHCCCCCCCCCHHH | 25.09 | 19608861 | |
221 | Ubiquitination | SSKVLDKPSRLTEKE CHHCCCCCCCCCHHH | 25.09 | 27667366 | |
222 | Phosphorylation | SKVLDKPSRLTEKEL HHCCCCCCCCCHHHH | 45.74 | 20068231 | |
223 | Ubiquitination | KVLDKPSRLTEKELA HCCCCCCCCCHHHHH | 54.90 | 32015554 | |
225 | Phosphorylation | LDKPSRLTEKELAEA CCCCCCCCHHHHHHH | 43.85 | 26074081 | |
225 | Ubiquitination | LDKPSRLTEKELAEA CCCCCCCCHHHHHHH | 43.85 | 33845483 | |
227 | Acetylation | KPSRLTEKELAEAAS CCCCCCHHHHHHHHH | 53.44 | 23954790 | |
227 | Sumoylation | KPSRLTEKELAEAAS CCCCCCHHHHHHHHH | 53.44 | 28112733 | |
227 | Ubiquitination | KPSRLTEKELAEAAS CCCCCCHHHHHHHHH | 53.44 | 32015554 | |
228 | Ubiquitination | PSRLTEKELAEAASK CCCCCHHHHHHHHHH | 47.16 | 27667366 | |
232 | Ubiquitination | TEKELAEAASKWAAE CHHHHHHHHHHHHHH | 16.07 | 33845483 | |
234 | Ubiquitination | KELAEAASKWAAEKL HHHHHHHHHHHHHHH | 35.46 | 32015554 | |
235 | Sumoylation | ELAEAASKWAAEKLE HHHHHHHHHHHHHHH | 35.80 | - | |
235 | Acetylation | ELAEAASKWAAEKLE HHHHHHHHHHHHHHH | 35.80 | 19608861 | |
235 | Sumoylation | ELAEAASKWAAEKLE HHHHHHHHHHHHHHH | 35.80 | 28112733 | |
235 | Ubiquitination | ELAEAASKWAAEKLE HHHHHHHHHHHHHHH | 35.80 | 32015554 | |
240 | Sumoylation | ASKWAAEKLEKSDES HHHHHHHHHHHCCHH | 58.16 | - | |
240 | Acetylation | ASKWAAEKLEKSDES HHHHHHHHHHHCCHH | 58.16 | 19608861 | |
240 | Sumoylation | ASKWAAEKLEKSDES HHHHHHHHHHHCCHH | 58.16 | 28112733 | |
240 | Ubiquitination | ASKWAAEKLEKSDES HHHHHHHHHHHCCHH | 58.16 | 19608861 | |
242 | Acetylation | KWAAEKLEKSDESNL HHHHHHHHHCCHHCC | 62.68 | 19608861 | |
242 | Ubiquitination | KWAAEKLEKSDESNL HHHHHHHHHCCHHCC | 62.68 | 32015554 | |
244 | Phosphorylation | AAEKLEKSDESNLPE HHHHHHHCCHHCCCC | 36.92 | 26074081 | |
244 | Ubiquitination | AAEKLEKSDESNLPE HHHHHHHCCHHCCCC | 36.92 | 33845483 | |
247 | Acetylation | KLEKSDESNLPEISE HHHHCCHHCCCCCCC | 48.97 | 19608861 | |
247 | Phosphorylation | KLEKSDESNLPEISE HHHHCCHHCCCCCCC | 48.97 | 26074081 | |
247 | Ubiquitination | KLEKSDESNLPEISE HHHHCCHHCCCCCCC | 48.97 | 27667366 | |
248 | Ubiquitination | LEKSDESNLPEISEY HHHCCHHCCCCCCCC | 58.53 | 23000965 | |
251 | Ubiquitination | SDESNLPEISEYEAG CCHHCCCCCCCCCCC | 63.41 | 33845483 | |
254 | Ubiquitination | SNLPEISEYEAGSTA HCCCCCCCCCCCCCC | 53.72 | 21890473 | |
255 | Phosphorylation | NLPEISEYEAGSTAP CCCCCCCCCCCCCCC | 12.32 | - | |
255 | Ubiquitination | NLPEISEYEAGSTAP CCCCCCCCCCCCCCC | 12.32 | 23000965 | |
261 | Ubiquitination | EYEAGSTAPLFTDQP CCCCCCCCCCCCCCC | 10.65 | 21890473 | |
267 | Ubiquitination | TAPLFTDQPEEPESN CCCCCCCCCCCCCCC | 44.22 | 23000965 | |
273 | Ubiquitination | DQPEEPESNTTHGIE CCCCCCCCCCCCCEE | 50.63 | 23000965 | |
273 (in isoform 3) | Ubiquitination | - | 50.63 | 21890473 | |
274 | Ubiquitination | QPEEPESNTTHGIEL CCCCCCCCCCCCEEE | 47.54 | 23000965 | |
280 | Ubiquitination | SNTTHGIELFEDSQL CCCCCCEEEECCCCC | 52.58 | 23000965 | |
280 (in isoform 6) | Ubiquitination | - | 52.58 | 21890473 | |
287 | Ubiquitination | ELFEDSQLTTRSKAI EEECCCCCCHHHHHH | 6.47 | 33845483 | |
298 | Phosphorylation | SKAIASKTKEIEQVY HHHHHHHHHHHHHHH | 31.26 | 20068231 | |
299 | 2-Hydroxyisobutyrylation | KAIASKTKEIEQVYR HHHHHHHHHHHHHHH | 61.50 | - | |
299 | Ubiquitination | KAIASKTKEIEQVYR HHHHHHHHHHHHHHH | 61.50 | 33845483 | |
303 | Ubiquitination | SKTKEIEQVYRQDCE HHHHHHHHHHHHHHH | 43.11 | 23000965 | |
305 | Phosphorylation | TKEIEQVYRQDCETF HHHHHHHHHHHHHHH | 11.40 | 22817900 | |
306 | Ubiquitination | KEIEQVYRQDCETFG HHHHHHHHHHHHHHH | 27.31 | 33845483 | |
309 | Ubiquitination | EQVYRQDCETFGMVV HHHHHHHHHHHHHHH | 3.92 | 21890473 | |
310 | Ubiquitination | QVYRQDCETFGMVVK HHHHHHHHHHHHHHH | 56.30 | 23000965 | |
311 (in isoform 6) | Phosphorylation | - | 31.64 | - | |
312 (in isoform 6) | Phosphorylation | - | 2.51 | 27067055 | |
316 | Ubiquitination | CETFGMVVKMLIEKD HHHHHHHHHHHHHCC | 1.93 | 21890473 | |
322 | Acetylation | VVKMLIEKDPSLEKS HHHHHHHCCCCHHHH | 68.87 | 26051181 | |
322 | Ubiquitination | VVKMLIEKDPSLEKS HHHHHHHCCCCHHHH | 68.87 | 23000965 | |
325 | Phosphorylation | MLIEKDPSLEKSIQF HHHHCCCCHHHHHHH | 60.33 | 25218447 | |
328 | Sumoylation | EKDPSLEKSIQFALR HCCCCHHHHHHHHHH | 59.14 | - | |
328 | Sumoylation | EKDPSLEKSIQFALR HCCCCHHHHHHHHHH | 59.14 | 28112733 | |
328 | Ubiquitination | EKDPSLEKSIQFALR HCCCCHHHHHHHHHH | 59.14 | 23000965 | |
328 (in isoform 1) | Ubiquitination | - | 59.14 | 21890473 | |
328 (in isoform 8) | Ubiquitination | - | 59.14 | 21890473 | |
329 | Phosphorylation | KDPSLEKSIQFALRQ CCCCHHHHHHHHHHH | 16.55 | 26074081 | |
329 | Ubiquitination | KDPSLEKSIQFALRQ CCCCHHHHHHHHHHH | 16.55 | 23000965 | |
335 | Ubiquitination | KSIQFALRQNLHEIE HHHHHHHHHCHHHHH | 21.66 | 21890473 | |
335 (in isoform 2) | Ubiquitination | - | 21.66 | 21890473 | |
340 (in isoform 9) | Phosphorylation | - | 52.17 | - | |
341 (in isoform 9) | Phosphorylation | - | 3.36 | 27067055 | |
359 (in isoform 8) | Phosphorylation | - | 5.36 | - | |
360 (in isoform 8) | Phosphorylation | - | 30.41 | 27067055 | |
366 (in isoform 2) | Phosphorylation | - | 68.69 | - | |
367 (in isoform 2) | Phosphorylation | - | 64.87 | 27067055 | |
396 | Phosphorylation | RKKRVRRTTQLRRTT CCHHHHHHHHHHHHH | 14.34 | 29496963 | |
397 | Phosphorylation | KKRVRRTTQLRRTTG CHHHHHHHHHHHHHC | 24.64 | 29496963 | |
403 | Phosphorylation | TTQLRRTTGAPDITW HHHHHHHHCCCCCCH | 29.54 | 28555341 | |
453 | Sumoylation | CNSRKDVKPENKQ-- CCCCCCCCCCCCC-- | 57.66 | - | |
453 | Sumoylation | CNSRKDVKPENKQ-- CCCCCCCCCCCCC-- | 57.66 | 25218447 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
110 | S | Phosphorylation | Kinase | AURKB | Q96GD4 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PPHLN_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PPHLN_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ASPP2_HUMAN | TP53BP2 | physical | 21900206 | |
SNCAP_HUMAN | SNCAIP | physical | 19730898 | |
A4_HUMAN | APP | physical | 21832049 | |
TSG10_HUMAN | TSGA10 | physical | 25416956 | |
CCD57_HUMAN | CCDC57 | physical | 25416956 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-235 AND LYS-240, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-201; THR-204 ANDSER-205, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133; SER-197 ANDSER-205, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133 AND SER-205, ANDMASS SPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-110; SER-121; SER-145;SER-155; THR-200; SER-201; THR-204; SER-205; SER-207 AND SER-208, ANDMASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-205, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121; SER-133; SER-140;THR-200 AND SER-201, AND MASS SPECTROMETRY. |